These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 2286698)

  • 21. Venlafaxine for treatment-resistant unipolar depression.
    Nierenberg AA; Feighner JP; Rudolph R; Cole JO; Sullivan J
    J Clin Psychopharmacol; 1994 Dec; 14(6):419-23. PubMed ID: 7884023
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of short-term venlafaxine versus lithium monotherapy for bipolar II major depressive episode: a randomized open-label study.
    Amsterdam JD; Shults J
    J Clin Psychopharmacol; 2008 Apr; 28(2):171-81. PubMed ID: 18344727
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tricyclic antidepressants in prepubertal depressed children: review of the literature.
    Weller RA; Weller EB
    Hillside J Clin Psychiatry; 1986; 8(1):46-55. PubMed ID: 3527932
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gender differences in treatment response to sertraline versus imipramine in patients with nonmelancholic depressive disorders.
    Baca E; Garcia-Garcia M; Porras-Chavarino A
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Jan; 28(1):57-65. PubMed ID: 14687858
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fluoxetine and desipramine in major depressive disorder.
    Bowden CL; Schatzberg AF; Rosenbaum A; Contreras SA; Samson JA; Dessain E; Sayler M
    J Clin Psychopharmacol; 1993 Oct; 13(5):305-11. PubMed ID: 8227488
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Application of a structured interview guide adapted to 4 depression scales].
    Fleck MP; Guelfi JD; Poirier-Littré MF; Lôo H
    Encephale; 1994; 20(5):479-86. PubMed ID: 7828510
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relationship between depression severity entry criteria and antidepressant clinical trial outcomes.
    Khan A; Schwartz K; Kolts RL; Ridgway D; Lineberry C
    Biol Psychiatry; 2007 Jul; 62(1):65-71. PubMed ID: 17141744
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neuroendocrine dysfunction and response to tricyclic antidepressants.
    Kirstein L
    J Clin Psychiatry; 1984 Sep; 45(9):385-6. PubMed ID: 6432772
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Pharmacological treatment of delusional depression].
    Amore M; Giordani L; Giorgetti G; Zazzeri N
    Minerva Psichiatr; 1996 Mar; 37(1):29-33. PubMed ID: 8804200
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antidepressant activity of 2-hydroxydesipramine.
    Nelson JC; Mazure C; Jatlow PI
    Clin Pharmacol Ther; 1988 Sep; 44(3):283-8. PubMed ID: 3416551
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Do depressed subjects who have failed both fluoxetine and a tricyclic antidepressant respond to the combination?
    Levitt AJ; Joffe RT; Kamil R; McIntyre R
    J Clin Psychiatry; 1999 Sep; 60(9):613-6. PubMed ID: 10520980
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 2-Hydroxydesipramine and desipramine plasma levels: how are they related to antidepressant response?
    Stern SL; Cooper TB; Nelson LD; Johnson MH; Suckow RF
    Int Clin Psychopharmacol; 1996 Dec; 11(4):219-27. PubMed ID: 9031987
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Desipramine versus phenelzine in recurrent unipolar depression: clinical characteristics and treatment response.
    Swann AC; Bowden CL; Rush AJ; Rhoades H; Rose R; Kobes R
    J Clin Psychopharmacol; 1997 Apr; 17(2):78-83. PubMed ID: 10950467
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lithium and desipramine versus desipramine alone in the treatment of severe major depression: a preliminary study.
    Cappiello A; McDougle CJ; Delgado PL; Malison RT; Jatlow P; Charney DS; Heninger GR; Price LH
    Int Clin Psychopharmacol; 1998 Sep; 13(5):191-8. PubMed ID: 9817623
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Drug-responsive symptoms in melancholia.
    Nelson JC; Mazure C; Quinlan DM; Jatlow PI
    Arch Gen Psychiatry; 1984 Jul; 41(7):663-8. PubMed ID: 6732425
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A double-blind, placebo-controlled trial of desipramine for primary alcohol dependence stratified on the presence or absence of major depression.
    Mason BJ; Kocsis JH; Ritvo EC; Cutler RB
    JAMA; 1996 Mar; 275(10):761-7. PubMed ID: 8598592
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cognitive improvement associated with tricyclic antidepressant treatment of childhood major depressive illness.
    Staton RD; Wilson H; Brumback RA
    Percept Mot Skills; 1981 Aug; 53(1):219-34. PubMed ID: 7290870
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of desipramine in depressed outpatients. Response according to research diagnosis criteria diagnoses and severity of illness.
    Stewart JW; Quitkin FM; Liebowitz MR; McGrath PJ; Harrison WM; Klein DF
    Arch Gen Psychiatry; 1983 Feb; 40(2):202-7. PubMed ID: 6337580
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predictors of response to desipramine in dysthymia.
    Friedman RA; Parides M; Baff R; Moran M; Kocsis JH
    J Clin Psychopharmacol; 1995 Aug; 15(4):280-3. PubMed ID: 7593711
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of DSM-III personality disorders on outcome of tricyclic antidepressant-treated nonpsychotic outpatients with major or minor depressive disorder.
    Reich JH
    Psychiatry Res; 1990 May; 32(2):175-81. PubMed ID: 2367602
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.